← FDA Drug Approvals (Drugs@FDA)

ZILBRYSQ

NDA · New Drug Application · Sponsor: UCB INC · Approved 2023-10-17

Drug application

FDA Application #

NDA216834

Application type

New Drug Application

Brand name

ZILBRYSQ

Generic name

ZILUCOPLAN

Active ingredients

ZILUCOPLAN SODIUM

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

UCB INC

Manufacturer

UCB, Inc.

First approval

2023-10-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown